日本語View as Markdown

Protective effect of hydrogen-rich saline on pressure overload-induced cardiac hypertrophyin rats: possible role of JAK-STAT signaling.

水素富化生理食塩水による圧負荷誘発性心肥大の抑制:JAK-STATシグナル経路の関与

animal study injection / infusion positive

Abstract

This study examined whether hydrogen-rich saline (HRS) exerts cardioprotective effects in a rat model of pressure overload induced by abdominal aortic constriction (AAC). Sixty Sprague-Dawley rats underwent AAC surgery and were allocated to four groups: sham, AAC-model, low-dose HRS (3 mL/kg/day intraperitoneally), and high-dose HRS (6 mL/kg/day intraperitoneally), each administered for 6 weeks. Heart weight-to-body weight and left ventricular weight-to-body weight ratios were elevated in the model group and reduced in both HRS groups in a dose-dependent manner. Elevated expression of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), along with cardiac fibrosis, were similarly suppressed by HRS. Janus kinase–signal transducer and activator of transcription (JAK-STAT) signaling molecule expression was downregulated following HRS administration, suggesting this pathway may mediate the observed cardioprotective effects.

Mechanism

HRS administration downregulated JAK-STAT signaling molecules, which was associated with reduced ANP and BNP expression and decreased cardiac fibrosis, suggesting that JAK-STAT pathway inhibition underlies the cardioprotective effect against pressure overload-induced hypertrophy.

Bibliographic

Authors
Fan Z, Gao Y, Huang Z, Xue F, Wu S, Yang J, et al.
Journal
BMC Cardiovasc Disord
Year
2018 (2018-02-13)
PMID
29433438
DOI
10.1186/s12872-018-0773-9
PMC
PMC5810059

Tags

Disease:心筋梗塞 Delivery:点滴投与 Mechanism:抗酸化酵素 炎症抑制 脂質過酸化 酸化ストレス 活性酸素種

Delivery context

Intravenous hydrogen-saline infusion is a clinic-only route and is not viable for everyday self-administration. For routine hydrogen intake, inhalation is the most practical route, but inhalation carries explosion risk and concentration matters (empirical LFL of 10%; high-concentration 66% / 100% devices are not recommended).

Safety notes

Intravenous hydrogen-saline infusion is a clinic-only route and is not viable for everyday self-administration. For routine hydrogen intake, inhalation is the most practical route, but inhalation carries explosion risk and concentration matters (empirical LFL of 10%; high-concentration 66% / 100% devices are not recommended).

See also:

Other papers on the same disease / condition

Cite as: H2 Papers — PMID 29433438. https://h2-papers.org/en/papers/29433438
Source: PubMed PMID 29433438